医学
结直肠癌
肠道菌群
微生物群
失调
恶性肿瘤
围手术期
癌症
肥胖
肠道微生物群
干预(咨询)
重症监护医学
内科学
生物信息学
外科
免疫学
精神科
生物
作者
José Ignacio Martínez‐Montoro,María Antonia Martínez-Sánchez,Andrés Balaguer Román,José Gil-Martínez,María José Mesa-López,Juan Egea Valenzuela,Antonio J. Ruiz‐Alcaraz,María Isabel Queipo-Ortuño,Miguel A. Ferrer,José Carlos Fernández‐García,Bruno Ramos‐Molina
标识
DOI:10.1016/j.ijsu.2022.106751
摘要
Colorectal cancer (CRC) is the third most frequent malignancy and the second cause of cancer death worldwide. Several factors have been postulated to be involved in CRC pathophysiology, including physical inactivity, unhealthy dietary habits, obesity, and the gut microbiota. Emerging data suggest that the microbiome may play a key role in CRC prognosis and derived complications in patients undergoing colorectal surgery. On the other hand, dietary intervention has been demonstrated to be able to induce significant changes in the gut microbiota and related metabolites in different conditions; therefore, the manipulation of gut microbiota through dietary intervention may constitute a useful approach to improve perioperative dysbiosis and post-surgical outcomes in patients with CRC. In this article, we review the role of the gut microbiota in CRC surgery complications and the potential therapeutic modulation of gut microbiome through nutritional intervention in patients with CRC undergoing surgery.
科研通智能强力驱动
Strongly Powered by AbleSci AI